Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Chubb
Deloitte
Colorcon
AstraZeneca
Farmers Insurance
McKesson
Federal Trade Commission

Generated: January 23, 2019

DrugPatentWatch Database Preview

Biomarin Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for BIOMARIN PHARM, and what generic alternatives to BIOMARIN PHARM drugs are available?

BIOMARIN PHARM has two approved drugs.

There are eleven US patents protecting BIOMARIN PHARM drugs.

There are seventy-nine patent family members on BIOMARIN PHARM drugs in twenty-four countries.

Summary for Biomarin Pharm
International Patents:79
US Patents:11
Tradenames:1
Ingredients:1
NDAs:2
Patent Litigation for Biomarin Pharm: See patent lawsuits for Biomarin Pharm

Drugs and US Patents for Biomarin Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biomarin Pharm KUVAN sapropterin dihydrochloride TABLET;ORAL 022181-001 Dec 13, 2007 RX Yes Yes RE43797*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride POWDER;ORAL 205065-001 Dec 19, 2013 RX Yes Yes 7,612,073*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride POWDER;ORAL 205065-001 Dec 19, 2013 RX Yes Yes 9,433,624 ➤ Try a Free Trial ➤ Try a Free Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride POWDER;ORAL 205065-001 Dec 19, 2013 RX Yes Yes 7,566,714*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride POWDER;ORAL 205065-002 Oct 27, 2015 RX Yes No 9,216,178 ➤ Try a Free Trial Y ➤ Try a Free Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride TABLET;ORAL 022181-001 Dec 13, 2007 RX Yes Yes 8,318,745*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride TABLET;ORAL 022181-001 Dec 13, 2007 RX Yes Yes 7,566,462*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for BIOMARIN PHARM drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Powder for Oral Solution 100 mg per packet ➤ Subscribe 2015-11-09
➤ Subscribe Tablets 100 mg ➤ Subscribe 2014-05-30
➤ Subscribe Powder for Oral Solution 500 mg/packet ➤ Subscribe 2016-12-20

International Patents for Biomarin Pharm Drugs

Country Document Number Estimated Expiration
European Patent Office 3138566 ➤ Try a Free Trial
Spain 2524026 ➤ Try a Free Trial
Israel 201101 ➤ Try a Free Trial
South Korea 20100016445 ➤ Try a Free Trial
South Korea 101721198 ➤ Try a Free Trial
Croatia P20121072 ➤ Try a Free Trial
Japan 2010523708 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
UBS
US Army
Moodys
Covington
Deloitte
Chinese Patent Office
Colorcon
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.